TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - News
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.26 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.28% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in TELO news today?
Telomir-Zn Study Demonstrates Dose-Dependent Survival, Reduced Hepatic Copper Burden: Telomir Pharmaceuticals published preclinical data showing Telomir-Zn delivered dose-dependent survival improvement and reduced hepatic copper burden, oxidative stress and liver injury biomarkers in an ATP7B-deficient zebrafish model of Wilson’s disease. The study also demonstrated attenuated intracellular calcium dysregulation, improved locomotor function and reduced tissue degeneration across multiple endpoints.
Bay Shore Trust bought 49.00K (~$343.00K) on Feb 13, 2024.
TELO Analyst Consensus
TELO analyst coverage data. Average price target: $0.00.
Common questions about TELO
What changed in TELO news today?
Telomir-Zn Study Demonstrates Dose-Dependent Survival, Reduced Hepatic Copper Burden: Telomir Pharmaceuticals published preclinical data showing Telomir-Zn delivered dose-dependent survival improvement and reduced hepatic copper burden, oxidative stress and liver injury biomarkers in an ATP7B-deficient zebrafish model of Wilson’s disease. The study also demonstrated attenuated intracellular calcium dysregulation, improved locomotor function and reduced tissue degeneration across multiple endpoints.
Does Rallies summarize TELO news?
Yes. Rallies summarizes TELO news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is TELO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TELO. It does not provide personalized investment advice.
